- Coordinator
- Agencia Estatal Consejo Superior De Investigaciones Cientificas, Spain
- Runs
- 1 April 2022 to 30 September 2026
- Status
- Running
- EU funding
- €3.0m
- Total cost
- €3.0m
- Partners
- 4 organisations in 3 countries
- Type
- European Innovation Council
- Grant agreement
- 101046927
What the project is doing
In the project's own words, from its summary on CORDIS.
Intracellular pathogens and viruses elicit immune responses by presenting their antigens to T cells. At the same time, they have evolved immune evasion mechanisms which essentially reduce the antigenic repertoire that is presented to the immune system. To overcome this problem, the EIC-funded ICARO project proposes to use silicon-based microchips that carry pathogen antigens and can be internalised by immune cells to aid antigen presentation.
These biochips are retained within cells for a long time and will provide the foundation for a novel vaccination strategy that can boost specific and long-lasting T cell responses. The consortium aims to develop standardized methods for ICARO manufacturing and functionalisation to be easily applicable to different pathogens, thus accelerating the generation of new vaccines in the future
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Coordinator |
| Interuniversitair Micro-Electronica Centrum | Leuven | Belgium | Participant |
| Arrays-For-Cell Nanodevices SL | Madrid | Spain | Participant |
| Centre National De La Recherche Scientifique CNRS | Paris | France | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI